WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...
InvestorsHub on MSN
Relmada Therapeutics shares jump 25% after promising bladder cancer trial results
Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD) climbed 25% on Monday after the company released 12-month interim results from its Phase 2 study of NDV-01 in patients with high-risk non-muscle ...
Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR ...
ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...
A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...
STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) has announced the addition of a new, non-invasive treatment for localized prostate cancer, which provides precision in ...
On Monday, members of the Lebanon City Fire Department were screen for esophageal cancer. It was conducted by Lucid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results